[Mindray Medical International Limited December 30, 2013 By Hand and EDGAR Cecilia Blye Chief, Office of Global Security Risk Mr. Pradip Bhaumik Special Counsel, Office of Global Security Risk Division of Corporation Finance 100 F. Street, N.E. Re: Mindray Medical International Limited Form 20-F for the fiscal year ended December 31, 2012 Filed April 8, 2013 File No. 1-33036 Dear]
[Mindray Medical International Limited December 30, 2013 By Hand and EDGAR Cecilia Blye Chief, Office of Global Security Risk Mr. Pradip Bhaumik Special Counsel, Office of Global Security Risk Division of Corporation Finance 100 F. Street, N.E. Re: Mindray Medical International Limited Form 20-F for the fiscal year ended December 31, 2012 Filed April 8, 2013 File No. 1-33036 Dear]
[Mindray Medical International Limited December30, 2013 By Hand and EDGAR Cecilia Blye Chief, Office of Global Security Risk Mr.Pradip Bhaumikecialunsel, Office of Global Security Risk Division ofrporation Finance 100 F. Street, N.E. Re: Mindray Medical International Limited Form 20-F for the fiscal year ended December31, 2012 Filed April8, 2013]
[Mindray Medical International Limited December30, 2013 By Hand and EDGAR Cecilia Blye Chief, Office of Global Security Risk Mr.Pradip Bhaumikecialunsel, Office of Global Security Risk Division ofrporation Finance 100 F. Street, N.E. Re: Mindray Medical International Limited Form 20-F for the fiscal year ended December31, 2012 Filed April8, 2013]
[Mindray Medical International Limitedmment 1: You stated in your letter to usted January19, 2011, that your non-U.S. operations sold products andmponents to distributors located in Cuba, Sudan, and Syria. You disclose that certain of your distributors are located in ornduct business with thoseuntries. you know, Cuba, Sudan and Syria are designated stateonsors of terrorism by]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 17, 2013. re-election At the meeting, Mindray shareholders approved the In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Companys independent registered public accounting]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 17, 2013. re-election At the meeting, Mindray shareholders approved the In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Companys independent registered public accounting]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutionsopted at its annual general meeting of shareholders held in Hong Kong on December17, 2013. re-election STYLE="font-family:Times New Roman" SIZE="2">At the meeting, Mindray shareholders approved the Indition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers thempanys independent]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutionsopted at its annual general meeting of shareholders held in Hong Kong on December17, 2013. re-election STYLE="font-family:Times New Roman" SIZE="2">At the meeting, Mindray shareholders approved the Indition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers thempanys independent]
